| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 1363089 |
|---|
| Description | Potent inhibitor of MET, VEGFR2, Ron and AXL (IC50 values are 0.4, 0.9, 3 and 11 nM, respectively). Also potently inhibits Tie-2, Flt-1, Flt-3, Flt-4, KIT, PDGFRα and PDGFRβ. Inhibits migration and invasion of B16F10 melanoma cells in vitro. Suppresses B16F10 tumor growth and metastasis in mice. Orally available. Purity 98%. MW (observed): 632.65 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide. XL 880, EXEL 2880, Foretinib |
|---|
| Gene, Accession, CAS # | CAS: 849217-64-7 |
|---|
| Catalog # | 6056/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK 1363089 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|